Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manon Launay

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Clinical Chemistry and Laboratory Medicine|August 14, 2024
Reply to: "Is uracil enough for effective pre-emptive DPD testing?"Fabienne Thomas, Manon Launay, Laure Raymond, et al.
Clinical Chemistry and Laboratory Medicine|June 19, 2024
Can we identify patients carrying targeted deleterious <i>DPYD</i> variants with plasma uracil and dihydrouracil? A GPCO-RNPGx retrospective analysisManon Launay, Laure Raymond, Jérôme Guitton, et al.
Clinical Pharmacology and Therapeutics|November 22, 2022
Plasma Uracil as a DPD Phenotyping Test: Pre-Analytical Handling Matters!Fabienne Thomas, Manon Launay, Jérôme Guitton, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 28, 2019
Belatacept-based immunosuppression: A calcineurin inhibitor-sparing regimen in heart transplant recipientsManon Launay, Joelle Guitard, Richard Dorent, et al.
Antibiotics (Basel, Switzerland)|July 16, 2020
Influence of Renal Function and Age on the Pharmacokinetics of Levofloxacin in Patients with Bone and Joint InfectionsGauthier Eloy, David Lebeaux, Manon Launay, et al.
The Journal of Antimicrobial Chemotherapy|November 2, 2023
Towards optimization of ceftazidime dosing in obese ICU patients: the end of the 'one-size-fits-all' approach?Patricia Correia, Manon Launay, Rémi Balluet, et al.
Therapeutic Drug Monitoring|August 1, 2022
Relationship Between Plasmatic Metformin Concentration and Renal Replacement Therapy: A Multicenter Cohort StudyLise Demaretz, Guillaume Claisse, Cornélie Fanton-D'Andon, et al.
Bulletin Du Cancer|August 15, 2018
[5-fluorouracil therapeutic drug monitoring: Update and recommendations of the STP-PT group of the SFPT and the GPCO-Unicancer]Florian Lemaitre, Françoise Goirand, Manon Launay, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 2020
Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 PatientsSophie Perinel, Manon Launay, Élisabeth Botelho-Nevers, et al.
Infection|December 28, 2023
Prospective assessment of the frequency of and risk factors for bleeding events in patients treated with cefazolinEmmanuelle Gras, Yohann Tran, Benjamin Kably, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Clinical Chemistry and Laboratory Medicine|August 14, 2024
Reply to: "Is uracil enough for effective pre-emptive DPD testing?"Fabienne Thomas, Manon Launay, Laure Raymond, et al.
Clinical Chemistry and Laboratory Medicine|June 19, 2024
Can we identify patients carrying targeted deleterious <i>DPYD</i> variants with plasma uracil and dihydrouracil? A GPCO-RNPGx retrospective analysisManon Launay, Laure Raymond, Jérôme Guitton, et al.
Clinical Pharmacology and Therapeutics|November 22, 2022
Plasma Uracil as a DPD Phenotyping Test: Pre-Analytical Handling Matters!Fabienne Thomas, Manon Launay, Jérôme Guitton, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 28, 2019
Belatacept-based immunosuppression: A calcineurin inhibitor-sparing regimen in heart transplant recipientsManon Launay, Joelle Guitard, Richard Dorent, et al.
Antibiotics (Basel, Switzerland)|July 16, 2020
Influence of Renal Function and Age on the Pharmacokinetics of Levofloxacin in Patients with Bone and Joint InfectionsGauthier Eloy, David Lebeaux, Manon Launay, et al.
The Journal of Antimicrobial Chemotherapy|November 2, 2023
Towards optimization of ceftazidime dosing in obese ICU patients: the end of the 'one-size-fits-all' approach?Patricia Correia, Manon Launay, Rémi Balluet, et al.
Therapeutic Drug Monitoring|August 1, 2022
Relationship Between Plasmatic Metformin Concentration and Renal Replacement Therapy: A Multicenter Cohort StudyLise Demaretz, Guillaume Claisse, Cornélie Fanton-D'Andon, et al.
Bulletin Du Cancer|August 15, 2018
[5-fluorouracil therapeutic drug monitoring: Update and recommendations of the STP-PT group of the SFPT and the GPCO-Unicancer]Florian Lemaitre, Françoise Goirand, Manon Launay, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 2020
Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 PatientsSophie Perinel, Manon Launay, Élisabeth Botelho-Nevers, et al.
Infection|December 28, 2023
Prospective assessment of the frequency of and risk factors for bleeding events in patients treated with cefazolinEmmanuelle Gras, Yohann Tran, Benjamin Kably, et al.
Pageof 5